IFOM Pubblicazioni 2011

Pubblicazioni 2011

In ordine cronologico - ultimo aggiornamento Novembre 2014
  1. An atlas of altered expression of deubiquitinating enzymes in human cancer.
    Luise C, Capra M, Donzelli M, Mazzarol G, Jodice MG, Nuciforo P, Viale G, Di Fiore PP, Confalonieri S
    PloS One. 2011 Jan 25;6(1):e15891.
    [PMID: 21283576] IF 4.411

  2. Clinical and Molecular Description of a Wilms Tumor in a Patient With Tuberous Sclerosis Complex
    Spreafico F, Notarangelo LD, Schumacher RF, Savoldi G, Gamba B, Terenziani M, Collini P, Fasoli S, Giordano L, Luisa B, Porta F, Massimino M, Radice P, Perotti D.
    American Journal of Medical Genetics Part A. 2011 Jun;155A(6):1419-24. doi: 10.1002/ajmg.a.34001. Epub 2011 May 12.
    [PMID: 21567926] IF 2.505

  3. ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.
    Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, Radice P, Stoppa-Lyonnet D, Tavtigian S, Wappenschmidt B, Couch FJ, Goldgar DE; ENIGMA.
    Human mutation. 2012 Jan;33(1):2-7. doi: 10.1002/humu.21628. Epub 2011 Nov
    [PMID: 21990146] IF 5.956

  4. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
    Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi V, Capra F, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H; OCGN, Thomassen M, Gerdes AM, Kruse TA, Cruger D, Jensen UB, Caligo MA, Olsson H, Kristoffersson U, Lindblom A, Arver B, Karlsson P, Stenmark Askmalm M, Borg Å, Neuhausen SL, Ding YC, Nathanson KL, Domchek SM, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Gronwald J, Górski B, Cybulski C, Debniak T, Osorio A, Durán M, Tejada MI, Benítez J, Hamann U, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Bodmer D, Ausems MG, van Os TA, Asperen CJ, Blok MJ, Meijers-Heijboer HE; HEBON; EMBRACE, Peock S, Cook M, Oliver C, Frost D, Dunning AM, Evans DG, Eeles R, Pichert G, Cole T, Hodgson S, Brewer C, Morrison PJ, Porteous M, Kennedy MJ, Rogers MT, Side LE, Donaldson A, Gregory H, Godwin A, Stoppa-Lyonnet D, Moncoutier V, Castera L, Mazoyer S, Barjhoux L, Bonadona V, Leroux D, Faivre L, Lidereau R, Nogues C, Bignon YJ, Prieur F, Collonge-Rame MA, Venat-Bouvet L, Fert-Ferrer S; GEMO Study Collaborators, Miron A, Buys SS, Hopper JL, Daly MB, John EM, Terry MB, Goldgar D; BCFR, Hansen Tv, Jønson L, Ejlertsen B, Agnarsson BA, Offit K, Kirchhoff T, Vijai J, Dutra-Clarke AV, Przybylo JA, Montagna M, Casella C, Imyanitov EN, Janavicius R, Blanco I, Lázaro C, Moysich KB, Karlan BY, Gross J, Beattie MS, Schmutzler R, Wappenschmidt B, Meindl A, Ruehl I, Fiebig B, Sutter C, Arnold N, Deissler H, Varon-Mateeva R, Kast K, Niederacher D, Gadzicki D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Simard J, Soucy P; kConFab Investigators, Spurdle AB, Holland H, Chenevix-Trench G, Easton DF, Antoniou AC; Consortium of Investigators of Modifiers of BRCA1/2.
    Journal of the National Cancer Institute. 2011 Jan 19;103(2):105-16. Epub 2010 Dec 17.
    [PMID: 21169536] IF 14.697

  5. Methylation status in patients with early stage colon cancer: A new prognostic marker?
    Zanutto S, Pizzamiglio S, Lampis A, Camerini T, Di Mauro MG, Pierotti MA, Verderio P, Gariboldi M.
    International Journal of Cancer. 2012 Jan 15;130(2):488-9. doi: 10.1002/ijc.26011. Epub 2011 Apr 25.
    [PMID: 21351098] IF 4.926

  6. NUMB-ing down cancer by more than just a NOTCH.
    Pece S, Confalonieri S, R Romano P, Di Fiore PP.
    Biochimica et Biophysica Acta Reviews on Cancer. 2011 Jan;1815(1):26-43. Epub 2010 Oct 16.
    [PMID: 20940030] IF 9.886

  7. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
    Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB; for HEBON, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C; for EMBRACE, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L; for GEMO Study Collaborators, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lázaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S; for kConFab Investigators, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K; for SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC; for the Consortium of Investigators of Modifiers of BRCA1/2.
    Cancer Epidemiology, Biomarkers & Prevention. 2012 Jan;21(1):134-147. Epub 2011 Dec 5.
    [PMID: 22144499] IF 4.19

  8. Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase.
    Oriente F, Iovino S, Cabaro S, Cassese A, Longobardi E, Miele C, Ungaro P, Formisano P, Blasi F, Beguinot F.
    Diabetes. 2011 Jan;60(1):138-47. Epub 2010 Sep 23.
    [PMID: 20864515] IF 8.889

  9. Proteomic snapshot of the EGF-induced ubiquitin network.
    Argenzio E, Bange T, Oldrini B, Bianchi F, Peesari R, Mari S, Di Fiore PP, Mann M, Polo S.
    Molecular Systems Biology. 2011 Jan 18;7:462.
    [PMID: 21245847] IF 9.667

  10. Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8.
    Manor U, Disanza A, Grati M, Andrade L, Lin H, Di Fiore PP, Scita G, Kachar B.
    Current Biology. 2011 Jan 25;21(2):167-72. Epub 2011 Jan 13.
    [PMID: 21236676] IF 10.025

  11. UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway.
    Pinato S, Gatti M, Scandiuzzi C, Confalonieri S, Penengo L.
    Molecular Cell Biology. 2011 Jan;31(1):118-26. Epub 2010 Nov 1
    [PMID: 21041483] IF 6.188

  12. Unclassified variants in BRCA genes: guidelines for interpretation.
    Radice P, De Summa S, Caleca L, Tommasi S
    Annals of Oncology. 2011 Jan;22 Suppl 1:i18-23
    [PMID: 21285146] IF 6.452

  13. The urokinase receptor in hematopoietic stem cells mobilization.
    Blasi F.
    Current Pharmaceutical Design. 2011;17(19):1911-3.
    [PMID: 21711240] IF 4.774

  14. Cobalamin deficiency-induced changes of epidermal growth factor (EGF)-receptor expression and EGF levels in rat spinal cord.
    Mutti E, Magnaghi V, Veber D, Faroni A, Pece S, Di Fiore PP, Scalabrino G.
    Brain Research. 2011 Feb 28;1376:23-30. Epub 2010 Dec 23.
    [PMID: 21185268] IF 2.263

  15. No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women.
    Beesley J, Johnatty SE, Chen X, Spurdle AB, Peterlongo P, Barile M, Pensotti V, Manoukian Si, Radice P, Kathleen Cuningham Consortium for Research in Familial Breast Cancer, Chenevix-Trench G.
    Breast Cancer Research and Treatment. 2011 Feb;126(1):235-9. Epub 2010 Dec 17.
    [PMID: 21165769] IF 4.859

  16. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.
    Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Zaffaroni D, Roversi Gaia, Ripamonti CB, Pasini B, Barile M, Viel A, Giannini G, Papi L, Varesco L, Martayan A, Riboni M, Volorio S, Radice P, Peterlongo P.
    Breast Cancer Research and Treatment. 2011 Feb;125(3):855-60. Epub 2010 Jul 22.
    [PMID: 20652397] IF 4.859

  17. Adhesion molecule signalling: not always a sticky business.
    Cavallaro U, Dejana E.
    Nature Reviews. 2011 Mar;12(3):189-97.
    [PMID: 21346732] IF 38.65

  18. HDACs link the DNA damage response, processing of double-strand breaks and autophagy.
    Robert T, Vanoli F, Chiolo I, Shubassi G, Bernstein KA, Rothstein R, Botrugno OA, Parazzoli D, Oldani A, Minucci S, Foiani M.
    Nature. 2011 Mar 3;471(7336):74-9.
    [PMID: 21368826] IF 36.101

  19. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.
    Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, dal Zuffo R, Matti V, d'Ario G, Montani E, Mercurio C, Hahn WC, Gorgoulis V, Minucci S, d'Adda di Fagagna F.
    Nature Cell Biology. 2011 Mar;13(3):292-302. Epub 2011 Feb 20.
    [PMID: 21336312] IF 19.407

  20. Secretory and endo/exocytic trafficking in invadopodia formation: the MT1-MMP paradigm.
    Frittoli E, Palamidessi A, Disanza A, Scita G.
    European Journal of Cell Biology. 2011 Feb-Mar;90(2-3):108-14.
    [PMID: 20605060] IF 3.63

  21. Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation.
    Maspero E, Mari S, Valentini E, Musacchio A, Fish A, Pasqualato S, Polo S.
    EMBO Reports. 2011 Apr;12(4):342-9. Epub 2011 Mar 11.
    [PMID: 21399620] IF 7.822

  22. The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migration.
    De Laurentiis A, Pardo OE, Palamidessi A, Jackson SP, Schoenwaelder SM, Reichmann E, Scita G, Arcaro A.
    Cellular Signalling. 2011 Mar;23(3):529-41. Epub 2010 Nov 5.
    [PMID: 21056654] IF 4.243

  23. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR.
    Dardaei L, Shahsavani R, Ghavamzadeh A, Behmanesh M, Aslankoohi E, Alimoghaddam K, Ghaffari SH.
    Clinical Biochemistry. 2011 Mar;44(4):325-30. Epub 2010 Dec 1
    [PMID: 21130081] IF 2.043

  24. The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery?
    Paolinelli R, Corada M, Orsenigo F, Dejana E.
    Pharmacological Research. 2011 Mar;63(3):165-71. Epub 2010 Dec 15.
    [PMID: 21167284] IF 3.612

  25. The TGF-β signaling modulators TRAP1/TGFBRAP1 and VPS39/Vam6/TLP are essential for early embryonic development.
    Messler S, Kropp S, Episkopou V, Felici A, Würthner J, Lemke R, Jerabek-Willemsen M, Willecke R, Scheu S, Pfeffer K, Wurthner JU.
    Immunobiology. 2011 Mar;216(3):343-50. Epub 2010 Aug 19.
    [PMID: 20961651] IF 4.114

  26. A zebrafish model for nevus regeneration.
    Richardson J, Zeng Z, Ceol C, Mione M, Jackson IJ, Patton EE.
    Pigment Cell & Melanoma Research. 2011 Apr;24(2):378-81. doi: 10.1111/j.1755-148X.2011.00839.x.
    [PMID: 21324102] IF 4.75

  27. Eps8 involvement in neuregulin1-ErbB4 mediated migration in the neuronal progenitor cell line ST14A.
    Fregnan F, Petrov V, Garzotto D, De Marchis S, Offenhäuser N, Grosso E, Chiorino G, Perroteau I, Gambarotta G.
    Experimental Cell Research. 2011 Apr 1;317(6):757-69. Epub 2011 Jan 31.
    [PMID: 21281626] IF 3.609

  28. Eps8 regulates hair bundle length and functional maturation of mammalian auditory hair cells.
    Zampini V, Rüttiger L, Johnson SL, Franz C, Furness DN, Waldhaus J, Xiong H, Hackney CM, Holley MC, Offenhauser N, Di Fiore PP, Knipper M, Masetto S, Marcotti W.
    PLoS Biology. 2011 Apr;9(4):e1001048. Epub 2011 Apr 19.
    [PMID: 21526224] IF 12.469

  29. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.
    Osorio A, Milne R L, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson K L, Domchek S M, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst F B, Verhoef S, van Dooren M F, Jager A, Ausems M G E M, Aalfs C M, van Asperen C J, Vreeswijk M, Waisfisz Q, Van Roozendaal C E, Ligtenberg M J, Easton D F, Peock S, Cook M, Oliver C T, Frost D, Curzon B, Evans D G, Lalloo F, Eeles R, Izatt L, Davidson R, Adlard J, Eccles D, Ong K-r, Douglas F, Downing S, Brewer C, Walker L, Nevanlinna H, Aittomäki K, Couch F J, Fredericksen Z, Lindor N M, Godwin A, Isaacs C, Caligo M A, Loman N, Jernström H, Barbany-Bustinza G, Liljegren A, Ehrencrona H, Stenmark-Askmalm M, Feliubadalò L, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Fortuzzi S, Johannsson O T, Chenevix-Trench G, Chen X-C, Beesley J, Spurdle A B, , Sinilnikova O M, Healey S, McGuffog L, Antoniou A C, Brunet J, Radice P, Benítez J.
    British Journal of Cancer. 2011 Apr 12;104(8):1356-61. Epub 2011 Mar 22.
    [PMID: 21427728] IF 4.831

  30. Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction.
    Santaguida S, Vernieri C, Villa F, Ciliberto A, Musacchio A.
    The EMBO Journal. 2011 Apr 20;30(8):1508-19. Epub 2011 Mar 15.
    [PMID: 21407176] IF 10.124

  31. Exploring the link between MORF4L1 and risk of breast cancer.
    Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, Kühl J, Neveling K, Schindler D, Ramírez MJ, Castellà M, Hernández G; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Davidson R, Ong KR, Cook J, Douglas F, Hodgson S, Brewer C, Morrison PJ, Porteous M, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Pasini B, Ottini L, Putignano AL, Savarese A, Bernard L, Radice P, Healey S, Spurdle A, Chen X, Beesley J; kConFab, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Asperen CJ, Bodmer D, Ausems MG, van Os TA, Blok MJ, Meijers-Heijboer HE, Hogervorst FB; HEBON, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR; SWE-BRCA, Harbst K, Borg Å, Rantala J, Barbany-Bustinza G, Ehrencrona H, Stenmark-Askmalm M, Kaufman B, Laitman Y, Milgrom R, Friedman E, Domchek SM, Nathanson KL, Rebbeck TR, Johannsson OT, Couch FJ, Wang X, Fredericksen Z, Cuadras D, Moreno V, Pientka FK, Depping R, Caldés T, Osorio A, Benítez J, Bueren J, Heikkinen T, Nevanlinna H, Hamann U, Torres D, Caligo MA, Godwin AK, Imyanitov EN, Janavicius R; GEMO Study Collaborators, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Ferrer SF, Collonge-Rame MA, Mortemousque I, McGuffog L, Chenevix-Trench G, Pereira-Smith OM, Antoniou AC, Cerón J, Tominaga K, Surrallés J, Pujana MA.
    Breast Cancer Research. 2011 Apr 5;13(2):R40.
    [PMID: 21466675] IF 5.785

  32. Is WTX a suitable target for cancer therapy?
    Perotti D, Radice P.
    Pediatric Blood & Cancer. 2011 Apr;56(4):682. doi: 10.1002/pbc.22947. Epub 2010 Dec 22.
    [PMID: 21298763] IF 1.948

  33. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.
    Peterlongo P, Catucci I, Pasquini G, Verderio P, Peissel B, Barile M, Varesco L, Riboni M, Fortuzzi S, Manoukian S, Radice P.
    Breast Cancer Research and Treatment. 2011 Apr;126(3):825-8. Epub 2010 Dec 24.
    [PMID: 21184274] IF 4.859

  34. Propagating cell-membrane waves driven by curved activators of actin polymerization.
    Peleg B, Disanza A, Scita G, Gov N.
    PloS One. 2011 Apr 21;6(4):e18635
    [PMID: 21533032] IF 4.411

  35. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase.
    Guarani V, Deflorian G, Franco CA, Krüger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M.
    Nature. 2011 May 12;473(7346):234-8. Epub 2011 Apr 17.
    [PMID: 21499261] IF 36.101

  36. Genomic instability in induced stem cells.
    Pasi CE, Dereli-Öz A, Negrini S, Friedli M, Fragola G, Lombardo A, Van Houwe G, Naldini L, Casola S, Testa G, Trono D, Pelicci PG, Halazonetis TD.
    Cell Death and Differentiation. 2011 May;18(5):745-53. Epub 2011 Feb 11
    [PMID: 21311564] IF 9.05

  37. Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1.
    Veggiani G, Ossolengo G, Aliprandi M, Cavallaro U, de Marco A
    Biochemical and Biophysical Research Communications. 2011 May 20;408(4):692-6. Epub 2011 Apr 24.
    [PMID: 21539817] IF 2.595

  38. Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression.
    Murakami M, Giampietro C, Giannotta M, Corada M, Torselli I, Orsenigo F, Cocito A, d'Ario G, Mazzarol G, Confalonieri S, Di Fiore PP, Dejana E.
    PloS One. 2011;6(6):e21242. Epub 2011 Jun 17
    [PMID: 21695058] IF 4.411

  39. Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.
    Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, Gariboldi Manuela, Pierotti MA, Daidone MG
    Breast Cancer Research and Treatment. 2011 Jun;127(3):601-10. Epub 2010 Jul 13.
    [PMID: 20625818] IF 4.859

  40. Genome-wide function of THO/TREX in active genes prevents R-loop-dependent replication obstacles
    Gómez-González B, García-Rubio M, Bermejo R, Gaillard H, Shirahige K, Marín A, Foiani M, Aguilera A.
    The EMBO Journal. 2011 Jun 24;30(15):3106-19. doi: 10.1038/emboj.2011.206.
    [PMID: 21701562] IF 10.124

  41. Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens.
    Pelosi G, Rossi G, Bianchi F, Maisonneuve P, Galetta D, Sonzogni A, Veronesi G, Spaggiari L, Papotti M, Barbareschi M, Graziano P, Decensi A, Cavazza A, Viale G.
    Journal of Thoracic Oncology. 2011 Jun;6(6):1039-49.
    [PMID: 21512408] IF 4.04

  42. MMSET Is Highly Expressed and Associated with Aggressiveness in Neuroblastoma.
    Hudlebusch HR, Skotte J, Santoni-Rugiu E, Zimling ZG, Lees MJ, Simon R, Sauter G, Rota R, De Ioris MA, Quarto M, Johansen JV, Jørgensen M, Rechnitzer C, Maroun LL, Schrøder H, Petersen BL, Helin K.
    Cancer Research. 2011 Jun 15;71(12):4226-35. Epub 2011 Apr 28.
    [PMID: 21527557] IF 4.19

  43. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
    Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D; BCFR Investigators, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, Brewster W, Brooks-Wilson A, Brown R, Butzow R, Caldes T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Doherty JA, Dörk T, Dürst M, Eccles DM, Ekici AB, Easton D; EMBRACE Investigators, Fasching PA, de Fazio A, Fenstermacher DA, Flanagan JM, Fridley BL, Friedman E, Gao B, Sinilnikova O; GEMO Study Collaborators, Gentry-Maharaj A, Godwin AK, Goode EL, Goodman MT, Gross J, Hansen TV, Harnett P, Rookus M; HEBON Investigators, Heikkinen T, Hein R, Høgdall C, Høgdall E, Iversen ES, Jakubowska A, Johnatty SE, Karlan BY, Kauff ND, Kaye SB, Chenevix-Trench G; kConFab Investigators and the Consortium of Investigators of Modifiers of BRCA1/2, Kelemen LE, Kiemeney LA, Kjaer SK, Lambrechts D, Lapolla JP, Lázaro C, Le ND, Leminen A, Leunen K, Levine DA, Lu Y, Lundvall L, Macgregor S, Marees T, Massuger LF, McLaughlin JR, Menon U, Montagna M, Moysich KB, Narod SA, Nathanson KL, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut JM, Sellers TA, Singer CF, Song H, Stram DO, Sutphen R, Lindblom A; SWE-BRCA Investigators, Terry KL, Tsai YY, van Altena AM, Vergote I, Vierkant RA, Vitonis AF, Walsh C, Wang-Gohrke S, Wappenschmidt B, Wu AH, Ziogas A, Berchuck A, Risch HA; Ovarian Cancer Association Consortium.
    Clinical Cancer Research. 2011 Jun 1;17(11):3742-50. Epub 2011 Mar 8.
    [PMID: 21385923] IF 7.338

  44. The three SMC sisters.
    Branzei D.
    Nature Reviews. 2011 Jun;12(6):343. Epub 2011 May 18.
    [PMID: 21587291] IF 38.65

  45. Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.
    Fernández-Ramires R, Gómez G, Muñoz-Repeto I, de Cecco L, Llort G, Cazorla A, Blanco I, Gariboldi M, Pierotti MA, Benítez J, Osorio A.
    International journal of cancer. 2011 Jun 1;128(11):2635-44. doi: 10.1002/ijc.25603. Epub 2010 Oct 8.
    [PMID: 20715112] IF 4.926

  46. Homeodomain transcription factor and tumor suppressor Prep1 is required to maintain genomic stability.
    Iotti G, Longobardi E, Masella S, Dardaei L, De Santis F, Micali N, Blasi F.
    PNAS. 2011 Jul 19;108(29):E314-22. Epub 2011 Jun 29
    [PMID: 21715654] IF 9.771

  47. Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.
    Molinari F, Felicioni L, Buscarino M, De Dosso S, Buttitta F, Malatesta S, Movilia A, Luoni M, Boldorini R, Alabiso O, Girlando S, Soini B, Spitale A, Di Nicolantonio F, Saletti P, Crippa S, Mazzucchelli L, Marchetti A, Bardelli A, Frattini M.
    Clinical Cancer Research. 2011 Jul 15;17(14):4901-14. Epub 2011 Jun 1.
    [PMID: 21632860] IF 7.338

  48. Never-ageing cellular senescence.
    Ogrunc M, d'Adda di Fagagna F.
    European Journal of Cancer. 2011 Jul;47(11):1616-22. Epub 2011 May 9.
    [PMID: 21561762] IF 4.944

  49. Signal integration and coincidence detection in the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) cascade: concomitant activation of receptor tyrosine kinases and of LRP-1 leads to sustained ERK phosphorylation via down-regulation of dual specificity phosphatases (DUSP1 and -6).
    Geetha N, Mihaly J, Stockenhuber A, Blasi F, Uhrin P, Binder BR, Freissmuth M, Breuss JM.
    The Journal of Biological Chemistry. 2011 Jul 22;286(29):25663-74. Epub 2011 May 24
    [PMID: 21610072] IF 5.328

  50. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
    Venturini L, Daidone MG, Motta R, Collini P, Spreafico F, Terenziani M, Piva L, Radice P, Perotti D, Zaffaroni N.
    Genes, Chromosomes & Cancer. 2011 Oct;50(10):823-9. doi: 10.1002/gcc.20903. Epub 2011 Jul 18.
    [PMID: 21769957] IF 3.99

  51. The Eps8/IRSp53/VASP network differentially controls actin capping and bundling in filopodia formation.
    Vaggi F, Disanza A, Milanesi F, Di Fiore PP, Menna E, Matteoli M, Gov NS, Scita G, Ciliberto A.
    PLoS Computational Biology. 2011 Jul;7(7):e1002088. Epub 2011 Jul 21
    [PMID: 21814501] IF 5.515

  52. The LRF transcription factor regulates mature B cell development and the germinal center response in mice.
    Sakurai N, Maeda M, Lee SU, Ishikawa Y, Li M, Williams JC, Wang L, Su L, Suzuki M, Saito TI, Chiba S, Casola S, Yagita H, Teruya-Feldstein J, Tsuzuki S, Bhatia R, Maeda T.
    The Journal of Clinical Investigation. 2011 Jul 1;121(7):2583-98. doi: 10.1172/JCI45682. Epub 2011 Jun 6
    [PMID: 21646720] IF 14.152

  53. The replication checkpoint protects fork stability by releasing transcribed genes from nuclear pores.
    Bermejo R, Capra T, Jossen R, Colosio A, Frattini C, Carotenuto W, Cocito A, Doksani Y, Klein H, Gómez-González B, Aguilera A, Katou Y, Shirahige K, Foiani M.
    Cell. 2011 Jul 22;146(2):233-46.
    [PMID: 21784245] IF 32.401

  54. The role of SNM1 family nucleases in etoposide-induced apoptosis.
    Hosono Y, Abe T, Ishiai M, Takata M, Enomoto T, Seki M.
    Biochemical and Biophysical Research Communications. 2011 Jul 8;410(3):568-73. Epub 2011 Jun 12.
    [PMID: 21683065] IF 2.595

  55. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer.
    Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, Pelosi G, Maisonneuve P, Veronesi G, Di Fiore PP.
    EMBO Molecular Medicine. 2011 Aug;3(8):495-503. doi: 10.1002/emmm.201100154. Epub 2011 Jul 11.
    [PMID: 21744498] IF 8.833

  56. Computational modelling of mitotic exit in budding yeast: the role of separase and Cdc14 endocycles.
    Vinod PK, Freire P, Rattani A, Ciliberto A, Uhlmann F, Novak B.
    Journal of the Royal Society Interface. 2011 Aug 7;8(61):1128-41. Epub 2011 Feb 2.
    [PMID: 21288956] IF 4.259

  57. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
    Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Birk Jensen U, Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E, Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B; SWE-BRCA, Nathanson KL, Domchek SM, Rebbeck T, Jakubowska A, Lubinski J, Gronwald J, Huzarski T, Byrski T, Cybulski C, Gorski B, Osorio A, Ramón y Cajal T, Fostira F, Andrés R, Benitez J, Hamann U, Hogervorst FB, Rookus MA, Hooning MJ, Nelen MR, van der Luijt RB, van Os TA, van Asperen CJ, Devilee P, Meijers-Heijboer HE, Gómez Garcia EB; HEBON, Peock S, Cook M, Frost D, Platte R, Leyland J, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Eccles D, Ong KR, Cook J, Douglas F, Paterson J, Kennedy MJ, Miedzybrodzka Z; EMBRACE, Godwin A, Stoppa-Lyonnet D, Buecher B, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Lasset C, Leroux D, Faivre L, Bronner M, Prieur F, Nogues C, Rouleau E, Pujol P, Coupier I, Frénay M; CEMO Study Collaborators, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Tea MK, Pfeiler G, Dressler AC, Hansen Tv, Jønson L, Ejlertsen B, Barkardottir RB, Kirchhoff T, Offit K, Piedmonte M, Rodriguez G, Small L, Boggess J, Blank S, Basil J, Azodi M, Toland AE, Montagna M, Tognazzo S, Agata S, Imyanitov E, Janavicius R, Lázaro C, Blanco I, Pharoah PD, Sucheston L, Karlan BY, Walsh CS, Olah E, Bozsik A, Teo SH, Seldon JL, Beattie MS, van Rensburg EJ, Sluiter MD, Diez O, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ruehl I, Varon-Mateeva R, Kast K, Deissler H, Niederacher D, Arnold N, Gadzicki D, Schönbuchner I, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Dumont M, Chiquette J, Tischkowitz M, Chen X, Beesley J, Spurdle AB; kConFab investigators, Neuhausen SL, Chun Ding Y, Fredericksen Z, Wang X, Pankratz VS, Couch F, Simard J, Easton DF, Chenevix-Trench G; CIMBA.
    Human Molecular Genetics. 2011 Aug 15;20(16):3304-21. Epub 2011 May 18.
    [PMID: 21593217] IF 8.058

  58. Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis.
    Bruni T, Mameli M, Pravettoni G, Boniolo G.
    Medicine, Health Care, and Philosophy. 2011 Aug 24.
    [PMID: 21863402] IF 0.726

  59. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice.
    Boulday G, Rudini N, Maddaluno L, Blécon A, Arnould M, Gaudric A, Chapon F, Adams RH, Dejana E, Tournier-Lasserve E
    The Journal of Experimental Medicine. 2011 Aug 29;208(9):1835-47. Epub 2011 Aug 22
    [PMID: 21859843] IF 14.776

  60. G-quadruplex-induced instability during leading-strand replication.
    Lopes J, Piazza A, Bermejo R, Kriegsman B, Colosio A, Teulade-Fichou MP, Foiani M, Nicolas A.
    EMBO Journal. 2011 Aug 26;30(19):4033-46. doi: 10.1038/emboj.2011.316.
    [PMID: 21873979] IF 10.124

  61. New insights into p53 based therapy.
    Lane DP, Brown CJ, Verma C, Cheok CF.
    Discovery Medicine. 2011 Aug;12(63):107-17
    [PMID: 21878188]

  62. The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.
    Zecchini S, Bombardelli L, Decio A, Bianchi M, Mazzarol G, Sanguineti F, Aletti G, Maddaluno L, Berezin V, Bock E, Casadio C, Viale G, Colombo N, Giavazzi R, Cavallaro U.
    EMBO Molecular Medicine. 2011 Aug;3(8):480-94. doi: 10.1002/emmm.201100152. Epub 2011 Jul 8.
    [PMID: 21739604] IF 8.833

  63. The signaling adaptor Eps8 is an essential actin capping protein for dendritic cell migration.
    Frittoli E, Matteoli G, Palamidessi A, Mazzini E, Maddaluno L, Disanza A, Yang C, Svitkina T, Rescigno M, Scita G.
    Immunity. 2011 Sep 23;35(3):388-99. Epub 2011 Aug 11.
    [PMID: 21835647] IF 24.221

  64. 1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
    Morello V, Cabodi S, Sigismund S, Camacho-Leal MP, Repetto D, Volante M, Papotti M, Turco E, Defilippi P.
    Oncogene. 2011 Sep 29;30(39):4087-96. doi: 10.1038/onc.2011.107. Epub 2011 Apr 11.
    [PMID: 21478906] IF 7.414

  65. Challenging the idea of corporate responsibility: physician's obligation to disclose information.
    Chiapperino L, Oishi JO
    American Journal of Bioethycs. 2011 Sep;11(9):20-1
    [PMID: 21877968] IF 3.986

  66. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
    Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg Å, Karlsson P, Askmalm MS, Bustinza GB; SWE-BRCA Collaborators, Nathanson KL, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ; HEBON; EMBRACE, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Bressac de Paillerets B, Caron O, Delnatte C; GEMO Study Collaborators, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB; Breast Cancer Family Registry, Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM; Consortium of Investigators of Modifiers of BRCA1/2
    Human Molecular Genetics. 2011 Dec 1;20(23):4732-47. Epub 2011 Sep 2.
    [PMID: 21890493] IF 8.058

  67. Extramitochondrial tricarboxylic acid cycle in retinal rod outer segments.
    Panfoli I, Calzia D, Ravera S, Bruschi M, Tacchetti C, Candiani S, Morelli Alessandro, Candiano G.
    Biochimie. 2011 Sep;93(9):1565-75. Epub 2011 Jun 13.
    [PMID: 21683117] IF 3.787

  68. Number and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membrane.
    Hellriegel C, Caiolfa VR, Corti V, Sidenius N, Zamai M.
    The FASEB Journal. 2011 Sep;25(9):2883-97. Epub 2011 May 20
    [PMID: 21602447] IF 6.515

  69. Ubiquitin family modifications and template switching.
    Branzei D.
    FEBS Letters. 2011 Sep 16;585(18):2810-7. Epub 2011 Apr 29.
    [PMID: 21539841] IF 3.601

  70. USP15 is a deubiquitylating enzyme for receptor-activated SMADs.
    Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, Enzo E, Moro S, Polo S, Dupont S, Cordenonsi M, Piccolo S.
    Nature Cell Biology. 2011 Sep 25;13(11):1368-75. doi: 10.1038/ncb2346.
    [PMID: 21947082] IF 19.407

  71. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
    Milne RL, Goode EL, García-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, Benítez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Cox A, Brock IW, Elliot G, Cross SS, Seal S, Turnbull C, Renwick A, Rahman N, Shen CY, Yu JC, Huang CS, Hou MF, Nordestgaard BG, Bojesen SE, Lanng C, Grenaker Alnæs G, Kristensen V, Børrensen-Dale AL, Hopper JL, Dite GS, Apicella C, Southey MC, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Chang-Claude J, Wang-Gohrke S, Radice P, Peterlongo P, Manoukian S, Barile M, Giles GG, Baglietto L, John EM, Miron A, Chanock SJ, Lissowska J, Sherman ME, Figueroa JD, Bogdanova NV, Antonenkova NN, Zalutsky IV, Rogov YI, Fasching PA, Bayer CM, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Meindl A, Heil J, Bartram CR, Schmutzler RK, Thomas GD, Hoover RN, Fletcher O, Gibson LJ, dos Santos Silva I, Peto J, Nickels S, Flesch-Janys D, Anton-Culver H, Ziogas A, Sawyer E, Tomlinson I, Kerin M, Miller N, Schmidt MK, Broeks A, Van't Veer LJ, Tollenaar RA, Pharoah PD, Dunning AM, Pooley KA, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Jakubowska A, Lubinski J, Jaworska K, Durda K, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Kraft P, Lindstrom S, Chen X, Beesley J, Hamann U, Harth V, Justenhoven C; GENICA Network, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Khusnutdinova E, Bermisheva M, Prokofieva D, Farahtdinova A, Olson JE, Wang X, Humphreys MK, Wang Q, Chenevix-Trench G; kConFab Investigators; AOCS Group, Easton DF.
    Cancer Epidemiology, Biomarkers & Prevention. 2011 Oct;20(10):2222-31. Epub 2011 Jul 27.
    [PMID: 21795498] IF 4.19

  72. Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.
    Sorio C, Mafficini A, Furlan F, Barbi S, Bonora A, Brocco G, Blasi F, Talamini G, Bassi C, Scarpa A.
    BMC Cancer. 2011 Oct 14;11:448. doi: 10.1186/1471-2407-11-448.
    [PMID: 21999221] IF 3.153

  73. Evidence for a link between TNFRSF11A and risk of breast cancer.
    Bonifaci N, Palafox M, Pellegrini P, Osorio A, Benítez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Mariette F, Bernard L, Radice P, Kaufman B, Laitman Y, Milgrom R, Friedman E, Sáez ME, Climent F, Soler MT, Diez O, Balmaña J, Lasa A, Ramón y Cajal T, Miramar MD, de la Hoya M, Pérez-Segura P, Caldés T, Moreno V, Urruticoechea A, Brunet J, Lázaro C, Blanco I, Pujana MA, González-Suárez E.
    Breast Cancer Research and Treatment. 2011 Oct;129(3):947-54. Epub 2011 May 4.
    [PMID: 21541702] IF 4.859

  74. Live-cell 3D super-resolution imaging in thick biological samples.
    Cella Zanacchi F, Lavagnino Z, Perrone Donnorso M, Del Bue A, Furia L, Faretta M, Diaspro A.
    Nature Methods. 2011 Oct 9;8(12):1047-9. doi: 10.1038/nmeth.1744.
    [PMID: 21983925] IF 20.717

  75. In vivo label-free three-dimensional imaging of zebrafish vasculature with optical projection tomography.
    Bassi A, Fieramonti L, D'Andrea C, Mione M, Valentini G.
    Journal of Biomedical Optics. 2011 Oct;16(10):100502.
    [PMID: 22029341] IF 3.188

  76. Small GTPase Rab5 participates in chromosome congression and regulates localization of the centromere- associated protein CENP-F to kinetochores.
    Serio G, Margaria V, Jensen S, Oldani A, Bartek J, Bussolino F, Lanzetti L
    PNAS. 2011 Oct 18;108(42):17337-42. Epub 2011 Oct 10
    [PMID: 21987812] IF 9.771

  77. Terminally differentiated astrocytes lack DNA damage response signaling and are radioresistant but retain DNA repair proficiency.
    Schneider L, Fumagalli M, d'Adda di Fagagna F.
    Cell Death and Differentiation. 2011 Oct 7. doi: 10.1038/cdd.2011.129. [Epub ahead of print].
    [PMID: 21979466] IF 9.05

  78. The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain.
    Peterlongo P, Caleca L, Cattaneo E, Ravagnani F, Bianchi T, Galastri L, Bernard L, Ficarazzi F, Dall'olio V, Marme F, Langheinz A, Sohn C, Burwinkel B, Giles GG, Baglietto L, Severi G, Odefrey FA, Southey MC, Osorio A, Fernández F, Alonso MR, Benítez J, Barile M, Peissel B, Manoukian S, Radice P.
    Journal of Medical Genetics. 2011 Oct;48(10):703-4.
    [PMID: 21931172] IF 7.037

  79. Toll-like receptor 9 agonist IMO cooperates with cetuximab in K-ras mutant colorectal and pancreatic cancers.
    Rosa R, Melisi D, Damiano V, Bianco R, Garofalo S, Gelardi T, Agrawal S, Di Nicolantonio F, Scarpa A, Bardelli A, Tortora G.
    Clinical Cancer Research. 2011 Oct 15;17(20):6531-41. Epub 2011 Sep 2.
    [PMID: 21890455] IF 7.338

  80. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
    Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, Janavicius R, Hansen Tv, Nielsen FC, Ejlertsen B, Osorio A, Muñoz-Repeto I, Durán M, Godino J, Pertesi M, Benítez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Bonanni B, Viel A, Pasini B, Papi L, Ottini L, Savarese A, Bernard L, Radice P, Hamann U, Verheus M, Meijers-Heijboer HE, Wijnen J, Gómez García EB, Nelen MR, Kets CM, Seynaeve C, Tilanus-Linthorst MM, van der Luijt RB, van Os T, Rookus M, Frost D, Jones JL, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Cook J, Donaldson A, Dorkins H, Gregory H, Eason J, Houghton C, Barwell J, Side LE, McCann E, Murray A, Peock S, Godwin AK, Schmutzler RK, Rhiem K, Engel C, Meindl A, Ruehl I, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Kast K, Preisler-Adams S, Varon-Mateeva R, Schoenbuchner I, Fiebig B, Heinritz W, Schäfer D, Gevensleben H, Caux-Moncoutier V, Fassy-Colcombet M, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Hardouin A, Berthet P, Muller D, Fricker JP, Mortemousque I, Pujol P, Coupier I, Lebrun M, Kientz C, Longy M, Sevenet N, Stoppa-Lyonnet D, Isaacs C, Caldes T, de la Hoya M, Heikkinen T, Aittomäki K, Blanco I, Lázaro C, Barkardottir RB, Soucy P, Dumont M, Simard J, Montagna M, Tognazzo S, D'Andrea E, Fox S, Yan M, Rebbeck T, Olopade O, Weitzel JN, Lynch HT, Ganz PA, Tomlinson GE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet M, Bhatia J, Kauff N, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Mai PL, Greene MH, Imyanitov E, O'Malley FP, Ozcelik H, Glendon G, Toland AE, Gerdes AM, Thomassen M, Kruse TA, Jensen UB, Skytte AB, Caligo MA, Soller M, Henriksson K, Wachenfeldt vA, Arver B, Stenmark-Askmalm M, Karlsson P, Ding YC, Neuhausen SL, Beattie M, Pharoah PD, Moysich KB, Nathanson KL, Karlan BY, Gross J, John EM, Daly MB, Buys SM, Southey MC, Hopper JL, Terry MB, Chung W, Miron AF, Goldgar D, Chenevix-Trench G, Easton DF, Andrulis IL, Antoniou AC; Breast Cancer Family Registry; EMBRACE; GEMO Study Collaborators; HEBON; kConFab Investigators; Ontario Cancer Genetics Network; SWE-BRCA; CIMBA.
    Breast Cancer Research. 2011 Nov 2;13(6):R110. [Epub ahead of print].
    [PMID: 22053997] IF 5.785

  81. Differential regulation of epiboly initiation and progression by zebrafish Eomesodermin A.
    Du S, Draper BW, Mione M, Moens CB, Bruce A.
    Developmental Biology. 2012 Feb 1;362(1):11-23. Epub 2011 Nov 18.
    [PMID: 22142964] IF 4.094

  82. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
    Magistroni V, Mologni L, Sanselicio S, Reid JF, Redaelli S, Piazza R, Viltadi M, Bovo G, Strada G, Grasso M, Gariboldi M, Gambacorti-Passerini C.
    PloS One. 2011;6(11):e28162. Epub 2011 Nov 30
    [PMID: 22140532] IF 4.411

  83. From filopodia to synapses: the role of actin-capping and anti-capping proteins.
    Menna E, Fossati G, Scita G, Matteoli M.
    European Journal of Neuroscience. 2011 Nov;34(10):1655-62. doi: 10.1111/j.1460-9568.2011.07897.x.
    [PMID: 22103422] IF 3.658

  84. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.
    Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubinski J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, Roozendaal CE; HEBON; EMBRACE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang X, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P, Ehrencrona H, Wachenfeldt Av; SWE-BRCA, Barkardottir RB, Hamann U, Rashid MU, Lasa A, Caldés T, Andrés R, Schmitt M, Assmann V, Stevens K, Offit K, Curado J, Tilgner H, Guigó R, Aiza G, Brunet J, Castellsagué J, Martrat G, Urruticoechea A, Blanco I, Tihomirova L, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB; BCFR, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Deissler H, Varon-Mateeva R, Sutter C, Niederacher D, Imyamitov E, Sinilnikova OM, Stoppa-Lyonne D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Fert Ferrer S, Collonge-Rame MA, Mortemousque I; GEMO Study Collaborators, Spurdle AB, Beesley J, Chen X, Healey S; kConFab, Barcellos-Hoff MH, Vidal M, Gruber SB, Lázaro C, Capellá G, McGuffog L, Nathanson KL, Antoniou AC, Chenevix-Trench G, Fleisch MC, Moreno V, Pujana MA.
    PLoS Biology. 2011 Nov;9(11):e1001199. Epub 2011 Nov 15
    [PMID: 22110403] IF 12.469

  85. Recruitment of Endophilin to Clathrin-Coated Pit Necks Is Required for Efficient Vesicle Uncoating after Fission.
    Milosevic I, Giovedi S, Lou X, Raimondi A, Collesi C, Shen H, Paradise S, O'Toole E, Ferguson S, Cremona O, Camilli PD.
    Neuron. Nov 17;72(4):587-601.
    [PMID: 22099461] IF 14.027

  86. Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations.
    Manoukian S, Peissel B, Frigerio S, Lecis D, Bartkova J, Roversi G, Radice P, Bartek J, Delia D.
    Breast Cancer Research and Treatment. 2011 Nov;130(1):207-15. Epub 2011 May 12.
    [PMID: 21562711] IF 5.785

  87. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
    Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS; HEBON, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer HE, Van Roozendaal CE, Caldes T, Perez-Segura P, Jakubowska A, Lubinski J, Huzarski T, Blecharz P, Nevanlinna H, Aittomäki K, Lázaro C, Blanco I, Barkardottir RB, Montagna M, D'Andrea E; kConFab, Devilee P, Olopade OI, Neuhausen SL, Peissel B, Bonanni B, Peterlongo P, Singer CF, Rennert G, Lejbkowicz F, Andrulis IL, Glendon G, Ozcelik H; Ontario Cancer Genetics Network, Toland AE, Caligo MA; SWE-BRCA, Beattie MS, Chan S; UKFOCR, Domchek SM, Nathanson KL, Rebbeck TR, Phelan C, Narod S, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Hansen TV, Osorio A, Benitez J, Durán M, Weitzel JN, Garber J, Hamann U; EMBRACE, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Eeles R, Izatt L, Paterson J, Brewer C, Hodgson S, Morrison PJ, Porteous M, Walker L, Rogers MT, Side LE, Godwin AK, Schmutzler RK, Wappenschmidt B, Laitman Y, Meindl A, Deissler H, Varon-Mateeva R, Preisler-Adams S, Kast K, Venat-Bouvet L, Stoppa-Lyonnet D, Chenevix-Trench G, Easton DF, Klein RJ, Daly MJ, Friedman E, Dean M, Clark AG, Altshuler DM, Antoniou AC, Couch FJ, Offit K, Gold B.
    Human Genetics. 2011 Nov;130(5):685-99. Epub 2011 May 20.
    [PMID: 21597964] IF 5.047

  88. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
    Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüning T; GENICA Network, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Gantcev SH, Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X; kConFab AOCS Management Group, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton LA, Sherman ME, Lissowska J, Chanock SJ, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB.
    Human Molecular Genetics. 2011 Dec 1;20(23):4693-706. Epub 2011 Aug 18.
    [PMID: 21852249] IF 8.058

  89. Epigenetic alterations associated with cellular senescence: A barrier against tumorigenesis or a red carpet for cancer?
    Decottignies A, d'Adda di Fagagna F.
    Seminars in Cancer Biology. 2011 Dec;21(6):360-6. Epub 2011 Sep 16.
    [PMID: 21946622] IF 7.758

  90. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
    Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van't Veer LJ, Tollenaar RA, Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I, Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska J, Hunter DJ, Hoover RN, Thomas GD, Milne RL, Arias Pérez JI, González-Neira A, Benítez J, Burwinkel B, Meindl A, Schmutzler RK, Bartrar CR, Hamann U, Ko YD, Brüning T, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova N, Zalutsky JV, Rogov YI, Antonenkova N, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chenevix-Trench G, Chen X, Peterlongo P, Bonanni B, Bernard L, Manoukian S, Wang X, Cerhan J, Vachon CM, Olson J, Giles GG, Baglietto L, McLean CA, Severi G, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, Cross SS, Pharoah PP, Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S, Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch FJ, Easton DF; GENICA Network; kConFab Investigators; Australian Ovarian Cancer Study Group.
    British Journal of Cancer. 2011 Dec 6;105(12):1934-9. doi: 10.1038/bjc.2011.448. Epub 2011 Oct 27.
    [PMID: 22033276] IF 4.831

  91. Reciprocal repression between P53 and TCTP.
    Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, Colaluca I, Viale G, Rodrigues-Ferreira S, Wynendaele J, Chaloin O, Hoebeke J, Marine JC, Di Fiore PP, Telerman A.
    Nature Medicine. 2011 Dec 11;18(1):91-9. doi: 10.1038/nm.2546.
    [PMID: 22157679] IF 25.43

  92. Shaping development with ESCRTs.
    Rusten TE, Vaccari T, Stenmark H.
    Nature Cell Biology. 2011 Dec 22;14(1):38-45. doi: 10.1038/ncb2381.
    [PMID: 22193162] IF 19.407

Programmi di Ricerca

ProgrammaRicerca

Ricercatori

ProgrammaRicerca